How could they know - it's a blinded trial.
- Forums
- ASX - By Stock
- NEU
- Ann: Neuren provides update on Fragile X and INTREPID trials
NEU
neuren pharmaceuticals limited
Add to My Watchlist
1.48%
!
$13.04

Ann: Neuren provides update on Fragile X and INTREPID trials, page-7
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$13.04 |
Change
0.190(1.48%) |
Mkt cap ! $1.598B |
Open | High | Low | Value | Volume |
$13.15 | $13.15 | $12.92 | $1.938M | 148.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 67 | $13.04 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$13.06 | 250 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 31 | 13.030 |
4 | 275 | 13.020 |
7 | 604 | 13.010 |
5 | 1223 | 13.000 |
4 | 1215 | 12.990 |
Price($) | Vol. | No. |
---|---|---|
13.060 | 507 | 4 |
13.070 | 942 | 6 |
13.080 | 879 | 7 |
13.090 | 1758 | 6 |
13.100 | 1776 | 7 |
Last trade - 10.39am 18/06/2025 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |
The Watchlist
MEM
MEMPHASYS LIMITED.
Professor John Aitken, Scientific Director
Professor John Aitken
Scientific Director
Previous Video
Next Video
SPONSORED BY The Market Online